Analysis of APL1beta28, a surrogate marker for Alzheimer Abeta42, indicates altered precision of gamma-cleavage in the brains of Alzheimer disease patients.
about
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkersImpact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade.A correlativity study of plasma APL1β28 and clusterin levels with MMSE/MoCA/CASI in aMCI patients.The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy VolunteersBiomarkers and Alzheimer spectrum.
P2860
Analysis of APL1beta28, a surrogate marker for Alzheimer Abeta42, indicates altered precision of gamma-cleavage in the brains of Alzheimer disease patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Analysis of APL1beta28, a surr ...... of Alzheimer disease patients.
@en
Analysis of APL1beta28, a surr ...... of Alzheimer disease patients.
@nl
type
label
Analysis of APL1beta28, a surr ...... of Alzheimer disease patients.
@en
Analysis of APL1beta28, a surr ...... of Alzheimer disease patients.
@nl
prefLabel
Analysis of APL1beta28, a surr ...... of Alzheimer disease patients.
@en
Analysis of APL1beta28, a surr ...... of Alzheimer disease patients.
@nl
P356
P1476
Analysis of APL1beta28, a surr ...... of Alzheimer disease patients.
@en
P2093
Masatoshi Takeda
Shinji Tagami
P356
10.1159/000283481
P577
2010-02-13T00:00:00Z